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Abstract
Background Arterial shunting during carotid endarterectomy (CEA) is essential in some patients because of
insufficient cerebral perfusion during cross-clamping. However, the optimal diagnostic modality identifying these
patients is still debated. None of the currently used modalities has been proved superior to another. The aim of this
study was to assess the cost-effectiveness of two modalities, stump pressure measurement (SPM) versus elec-
troencephalography (EEG) combined with transcranial Doppler (TCD) during CEA.
Methods Two retrospective cohorts of consecutive patients undergoing CEA with different intraoperative neu-
romonitoring strategies (SPM vs. EEG/TCD) were analyzed. Clinical data were collected from patient hospital
records. Primary clinical outcome was in-hospital stroke or death. Total admission costs were calculated based on
volumes of healthcare resources. Analyses of effects and costs were adjusted for clinical differences between patients
by means of a propensity score, and cost-effectiveness was estimated.
Results A total of 503 (239 SPM; 264 EEG/TCD) patients were included, of whom 19 sustained a stroke or died
during admission (3.3 vs. 4.2%, respectively, adjusted risk difference 1.3% (95% CI -2.3–4.8%)). Median total costs
were €4946 (IQR 4424–6173) in the SPM group versus €7447 (IQR 6890–8675) in the EEG/TCD group. Costs for
neurophysiologic assessments were the main determinant for the difference.
Conclusions Given the evidence provided by this small retrospective study, SPM would be the favored strategy for
intraoperative neuromonitoring if cost-effectiveness was taken into account when deciding which strategy to adopt.
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Introduction
Carotid endarterectomy (CEA) is a prophylactic intervention
to prevent future ischemic events in patients with a symp-
tomatic carotid stenosis. However, patients involved are
exposed to a perioperative stroke or death risk of approxi-
mately 3%, of which one-third occurs intraoperatively due to
embolization or cerebral ischemia during cross-clamping
[1–4]. The use of a shunt might reduce cerebral ischemia by
maintaining ipsilateral flow but is still debated since it has
only been shown necessary in 10–14% of patients under-
going CEA under local or regional anesthesia, which can be
considered as reference standard. [5–7]. Moreover, shunting
itself is associated with complications too, including
atheromatous or air emboli, arterial dissection, and acute
arterial occlusion [8–11]. Therefore, many surgeons advo-
cate selective shunting, instead of routine shunting, in those
patients at high risk of cerebral ischemia.Methods frequently
used to evaluate cerebral perfusion during cross-clamping
and therewith the need for selective shunting include com-
puterized electroencephalography (EEG), transcranial
Doppler (TCD), stump pressure measurement (SPM), and
neurologic examination when CEA is performed under
regional or local anesthesia. None of these methods has been
proved to be superiorwith regard to intraoperative stroke risk
reduction [9]. These methods do, however, differ in labor
intensity and might consequently be associated with differ-
ent costs and/or cost-effectiveness.
Considering the increasing costs of healthcare and
decreasing health resources, costs might be taken into
account when deciding which strategy to adopt. The pri-
mary aim of this study was to assess the cost-effectiveness
of two modalities used to assess cerebral perfusion after
cross-clamping: SPM versus combined EEG and TCD.
Methods
Study design and patients
All consecutive patients who underwent CEA between
January 2005 and December 2014 in two midsize teaching
hospitals (Onze Lieve Vrouwe Gasthuis Amsterdam, hos-
pital A; Sint Lucas Andreas Ziekenhuis Amsterdam, hos-
pital B; the Netherlands) were included in this study.
Patients undergoing synchronous coronary artery bypass
grafting, patients initially admitted for another reason but
whom underwent a CEA during the admission because of
an in-hospital TIA or stroke, and those for whom medical
records were not available or costs could not be extracted
from the hospital information systems were excluded,
leaving 503 evaluable admissions for CEA (Fig. 1).
Demographics, comorbidities, cardiovascular risk fac-
tors, procedural details, and postoperative outcome were
collected from patient hospital records (operation reports,
radiology reports, and correspondence). Volumes of
healthcare resources from the index admission were
extracted from the hospital information systems.
Retrospective patients’ files research is not under the
scope of the Dutch ACT on Medical Scientific Research
involving Human Beings (WMO). The institutional review
board approved the protocol, data collection, and study
design (WO 15.007), and therefore, patient informed con-
sent was not required. Patient data were analyzed
anonymously.
Shunting strategy
Except for shunting strategy, the procedure of CEA was
similar in both hospitals including arteriotomy with patch
closure. In hospital A, SPM was used to determine the need
for a shunt, and in hospital B, EEG combined with TCD.
SPM was performed using a 21-gauge needle connected to
a pressure transducer by a fluid-filled pressurized tubing.
Prior to cross-clamping, systolic blood pressure was
brought to baseline (preoperative) values and the pressur-
ized system was zero-referenced against ambient atmo-
spheric pressure, keeping the needle at level of the
common carotid artery. After cross-clamping the external
and common carotid arteries, the needle was inserted into
the common carotid artery distally to the clamp. A systolic
stump pressure lower than 50 mmHg was considered
indicative for shunt insertion. The procedures for EEG
monitoring and TCD assessment in hospital B have been
described in detail elsewhere [12, 13]. Standard neuro-
physiologic assessments consisted of EEG monitoring and
TCD assessment prior to as well as during CEA, and TCD
postoperatively.
Cost analysis
This analysis was performed from a provider perspective
taking into account true costs made during the index
hospital admission, defined as the admission for sched-
uled CEA. For cost analysis, all costs associated with the
index admission were considered using standardized
methods [14]. Costs made before admission or after dis-
charge from hospital were not taken into account. All unit
costs were derived and calculated from the 2013 financial
ledger of hospital A, using activity-based costing to
accurately measure operation costs for CEA and hospital
day unit costs (intensive care unit costs and general ward
costs were defined separately). Hospital day unit costs
included the costs for physician care, nursing, materials,
medication, writing-off equipment, housing, and other
2960 World J Surg (2017) 41:2959–2967
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overhead costs. Operation costs include specialist’ fee,
costs of personnel, equipment, materials, and overhead
costs. Additional costs for the department of clinical
neurophysiology for performing perioperative EEG and
TCD were calculated separately for those patients treated
in hospital B and also include specialist ‘fee’ cost for
personnel equipment, materials, and overhead costs.
Volumes of blood products, radiology, laboratory tests,
physiotherapy, consultation of other specialties, etc., were
extracted from the hospital information systems. Total
costs were calculated as the summed product of volumes
and resources used and their corresponding unit costs.
Because costs between the two hospitals might differ due
to contracts with different suppliers of materials and
equipment, and the fact that healthcare reimbursements in
the Netherlands are based upon agreements between
individual hospitals and insurance companies, costs were
calculated as if all patients had been treated in the same
hospital (hospital A).
Primary outcome measures for the cost-effectiveness
analyses were in-hospital stroke or death, which was obtained
from medical records and all costs associated with the
admission. This primary end point was chosen since stroke
and death were assumed to influence hospital costs due to
longer hospital stay, including ICU admission, and costs for
instance additional imaging and specialist’ consultation.
Secondary outcome measures were hospital stay, duration of
operation (total time between entering and leaving the oper-
ation room), shunt use, and complication rate.
Statistical analysis
Descriptive statistics (mean, median, proportion) of patient
characteristics were determined stratified by hospital.
Adjustment for difference in patient characteristics
between both strategies, i.e., confounding, was done by
propensity score analysis [15]. First, a logistic regression
model was fit, regressing the strategy on multiple
CEAs performed between January 1st 2005 and December 31th 2014 identified from the 
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Fig. 1 CEAs performed between January 1, 2005, and December 31, 2014, identified from the institutions hospital information system
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confounders, i.e., patients’ age, sex, blood pressure (hy-
pertension vs. normal tension), coronary artery disease,
PAD, diabetes mellitus, history of smoking, indication for
the CEA, and degree of ipsilateral and contralateral
stenosis. Subsequently, the estimated propensity scores,
summarizing the information of multiple confounders,
were included as a single covariate in the models esti-
mating the differences in outcome incidence and costs
between the two strategies. The effect of strategy on the
incidence of outcome was quantified by means of a risk
difference. Therefore, both effects and costs were esti-
mated by means of a linear regression model, resulting in
estimates of the risk difference in outcome and the differ-
ence in costs between the two hospitals, each with corre-
sponding 95% confidence intervals. Then, the joint cost-
effectiveness was estimated by plotting 1000 bootstrap
estimates of costs and effects in a cost-effectiveness plane
[16].
A sensitivity analysis was performed to assess the
potential impact of misclassification on the outcome,
specifically to assess the impact of an event going unde-
tected in one of the two hospitals. For that, a random
subject who did not experience the outcome was assumed
to have the outcome and all analyses were repeated. This
procedure was repeated 1000 times, and estimates of costs
and effects were plotted in a cost-effectiveness plane.
Calculations were done separately for the SPM and the
EEG/TCD groups. All analyses were performed in R for




A total of 503 admissions for CEA were included in this
study (Fig. 1). Seventy-one percent was male. The mean
age was 69.5 ± 9.9 years. The vast majority of patients
(97.4%) had symptomatic carotid disease. SPM was used in
239 CEAs, EEG/TCD in 264. The technical success rate
was 98.3% for SPM and 93.2% for EEG/TCD (in 6.8%
only EEG recordings were used due to an absent temporal
window). The EEG/TCD group was slightly older and
consisted of more female patients. Moreover, less con-
comitant peripheral vascular disease has been recorded in
this group. Patient demographics and indication for treat-
ment are shown in Table 1.
Clinical outcome
The mean overall operation time did not differ between the
two strategies (SPM 145 ± 34 min; EEG/TCD
148 ± 31 min; P = 0.36). SPM indicated shunt use in 113
patients (47.3%) and EEG/TCD in 28 patients (10.6%).
Contralateral occlusion was associated with a higher shunt
rate (69 vs. 23%, relative risk 3.0; 95% CI 2.3–3.9).
Median hospital stay was 4 days (IQR 3–6) after SPM
versus 3 days (IQR 3–5) after EEG/TCD (Table 2).
In-hospital stroke or death rate did not differ between
the two strategies (SPM 3.3% vs. EEG/TCD 4.2%; adjus-
ted risk difference 1.3% (95% CI -2.3–4.8%)). There were
four postoperative deaths of which two following a stroke.
Of all 17 perioperative strokes, five had an intraoperative
Table 1 Baseline characteristics of both cohorts





Age, mean ± SD (years) 68.6 ± 9.2 70.3 ± 10. 5 0.045
Sex, male 181 (75.7) 178 (67.4) 0.050
Risk factors
Hypertension 144 (60.3) 166 (62.9) 0.608
CAD 66 (27.6) 71 (26.9) 0.935
PAD 55 (23.0) 35 (13.3) 0.006
Diabetes mellitus 62 (25.9) 76 (28.8) 0.539
History of smoking 184 (77.0) 187 (70.8) 0.143
Index event
Asymptomatic 8 (3.3) 5 (1.9) 0.654
Amaurosis fugax 56 (23.4) 57 (21.6)
TIA 78 (32.6) 95 (36.0)
Stroke 97 (40.6) 107 (40.5)
Time index event to CEA#
0–3 days 3 (1.4) 4 (1.8) 0.227a
4–7 days 27 (12.8) 17 (7.6)
8–14 days 73 (34.8) 73 (32.4)
[14 days 107 (51.0) 131 (58.2)
Degree of ispilateral stenosis
50–99% 29 (12.1) 37 (14.0) 0.623
70–99% 210 (87.9) 227 (86.0)
Degree of contralateral stenosis$
0–69% 182 (76.2) 210 (79.5) 0.287
70–99% 29 (12.1) 34 (12.9)
Occlusion 28 (11.7) 20 (7.6)
SPM stump pressure measurement, EEG electroencephalography,
TCD transcranial Doppler, SD standard deviation, CAD coronary
artery disease, PAD peripheral artery disease, TIA transient ischemic
attack
# Exact date of event was retrievable for 210 patients in the SPM
group and 225 patients in the EEG/TCD group
$ The granularity of recording of contralateral stenosis did not allow
for further categorization of stenosis\70%
a Based on likelihood ratio test
2962 World J Surg (2017) 41:2959–2967
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onset (SPM two; EEG/TCD three), eight occurred post-
operatively (four in both groups), and four were associated
with hyperperfusion syndrome (SPM one; EEG/TCD
three). A shunt had been used in three (SPM one; EEG/
TCD two) out of five patients suffering an intraoperative
stroke.
Costs, cost-effectiveness, and uncertainty assessment
Median total costs of hospitalization for CEA were €4946
(IQR 4424–6173) in the SPM group versus €7447 (IQR
6890–8675) in the EEG/TCD group (P\ 0.001). The
adjusted difference in costs was €2053 (95% CI
1424–2682). Main determinant for this difference was the
costs for neurophysiologic assessments (mean €2012 per
patient). In both groups, there were no differences in hos-
pital costs between patients in whom a shunt had been
inserted and those in whom had not: SPM €4864 (IQR
4476–5836) versus €4979 (IQR 4727–6030), P = 0.192;
EEG/TCD €7445 (IQR 6890–8680) versus €7523 (IQR
6923–9064), P = 0.638. Table 3 shows the mean resource
use and corresponding costs in both cohorts.
Figure 2 shows the ninety-five percent confidence
ellipse of the cost difference between the different strate-
gies. The bootstrapping results are almost divided equally
between both upper quadrants of the figure, indicating no
significant difference in stroke/death rates, but higher costs
in the EEG/TCD group.
A sensitivity analysis showed that misclassification of
an event in one of the both groups would not materially
impact the results of the cost-effectiveness analysis as
shown in Fig. 2 (Fig. 3).
Discussion
This study shows that SPM was less costly without a sig-
nificant difference in adverse events in terms of stroke or
death rate compared to EEG/TCD. The mean adjusted
difference in total admission costs for CEA was €2053 and
largely attributable to the perioperative neurophysiologic
assessments when using EEG/TCD. Perioperative mor-
bidity and mortality in our cohorts were comparable to
those found in other CEA studies. We consider our cost-
effectiveness analysis of interest. The different modalities
used in the participating hospitals have been chosen for
reasons in the past. SPM is less frequently used nowadays
since it does not provide any information on cerebral per-
fusion following cross-clamping and neither accounts for
the occurrence of cerebral ischemia during plaque removal
and arterial reconstruction. EEG/TCD does, on the other
hand, provide this information, but no benefit in terms of
perioperative stroke risk reduction can be found in the
Table 2 Operative and clinical outcome
Variable SPM EEG/TCD P value
n = 239 n = 264
Stump pressure, mean ± SD (mmHg) 48.2 ± 19.6 –
Use of shunt, no (%) 113 (47.3) 28 (10.6) \0.001
Operation time,a mean ± SD (min) 145 ± 34 148 ± 31 0.36
Hospital stay, median (IQR) (days) 4 (3-6) 3 (3-5) \0.001
Complication, no (%)
None 200 (83.7) 226 (85.6) \0.001b
Bleeding 9 (3.8) 23 (8.7)
Myocardial infarction 3 (1.3) 0
Non-fatal stroke 5 (2.1) 10 (3.8)
Death 3 (1.3) 1 (0.4)
Nerve injury 13 (5.4) 2 (0.8)
Other 6 (2.5) 2 (0.8)
Stroke/death, no (%) 8 (3.3) 11 (4.2) 0.63
Re-intervention no (%) 14 (5.9) 12 (4.5) 0.51
Total costs (€), median (IQR) 4946 (4424–6173) 7447 (6890–8675) \0.001
SPM stump pressure measurement, EEG electroencephalography, TCD transcranial Doppler SD standard deviation, IQR interquartile range
a Time interval between entering and leaving the operation room
b Based on likelihood ratio test
World J Surg (2017) 41:2959–2967 2963
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literature. EEG/TCD is, however, associated with higher
costs.
A reason to adopt a selective shunting strategy instead of
routine shunting can be the fact that shunts are not neces-
sarily benign and have been associated with complications
[17–20]. The shunt rate in the SPM group was quite high,
probably due to the chosen systolic cutoff point of
50 mmHg as indicative for shunt insertion. Yet, the opti-
mal stump pressure cutoff point is still controversial.
Several studies attempted to determine an optimal stump
pressure threshold in patients undergoing CEA under
regional anesthesia and found increasing accuracy by
lowering the threshold from 50 to 40 mmHg. Unnecessary
shunt use decreased by 20–25%, and the erroneously non-
shunted rate was kept between one and three percent
[7, 8, 21]. The threshold for shunt insertion in hospital A
may therefore have resulted in the unnecessary high shunt
rate. Since three out of five intraoperative strokes in this
study occurred in shunted patients, the threshold for shunt
insertion was lowered to 40 mmHg after the study. It is,
however, not certain that the intraoperative stroke in those
three shunted patients was due to the shunt placement
itself. The actual need for a shunt might indicate that these
patients were prone for ischemia anyway Moreover, in
search for the ideal stump pressure, a certain number of
false-positive outcomes (unnecessary use of a shunt) have
Table 3 Volumes and costs per patient of healthcare resources
Cost item Unit costs (€) Mean resource use per patient Mean costs per patient (€)
SPM EEG/TCD SPM EEG/TCD
Hospitalization (per day)
General ward 437.97 5.400 4.900 2365.04 2146.05
ICU 1110.53 0.060 0.261 66.63 290.25
Surgery (mean)
Primary operation 2969.00 1.000 1.000 2969.00 2933.80$
Reoperation 1855.22 0.059 0.045 108.60 84.33
Diagnostics
Neurophysiologic assessment
EEG 380.65 1.041 391.26
TCD 177.51 2.250 399.40
Complete intraoperative monitoring (EEG ? TCD) 1217.00 0.932 1134.24
Radiology
X-ray thorax 28.55 0.295 0.186 8.42 5.30
Ultrasound neck 80.73 0.047 0.144 3.63 11.62
CT brain 111.80 0.053 0.136 5.93 15.25
MRI brain 390.75 0.003 0.024 1.17 9.26
Other diagnostic modality 0.076 0.109 14.05 7.83
Laboratory tests
HCC 25.397 25.977 43.99 54.37
Microbiology 0.870 0.0678 17.95 13.01
Consultation#
Physiotherapy 57.39 0.071 1.078 4.08 61.84
Occupational therapy 28.69 0.833 0.159 23.81 4.56
Speech therapy 69.29 0.326 0.144 22.61 7.87
Other costs 283.93 499.01
Total 5938.90 7994.98
(total median costs per patient) (4946.00) (7447)
SPM stump pressure measurement, EEG electroencephalography, TCD transcranial Doppler, ICU intensive care unit, CT computed tomography,
MRI magnetic resonance imaging, HCC hematology and clinical chemistry
# Per consult
$ Average shunt use included in price
} Both EEG and TCD registered in 93% of all patients
2964 World J Surg (2017) 41:2959–2967
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to be accepted in order to keep the false negative (erro-
neously not-shunted patients) as low as possible.
On the contrary, the shunt rate found in our EEG/TCD
group approaches those found in studies where CEA was
performed in awake patients, which is considered as ref-
erence standard [5, 7, 21]. EEG and TCD allow for con-
tinuous monitoring and can therefore, in contrast to SPM,
also detect a malfunctioning shunt. Moreover, TCD pro-
vides information about the occurrence of microemboli,
allowing adaptation of surgical technique and handling
and might also be useful in the early postoperative phase
to predict cerebral hyperperfusion syndrome (CHS) and
upcoming thrombotic stroke [22–24]. This shunt rate is,
however, not necessarily worth pursuing, since low false-
positive rates usually come at the expense of the sensi-
tivity. Only few studies have determined the accuracy of
EEG recordings in awake patients (reference standard).
These studies show positive predictive values (PPVs) of
EEG detecting true neurologic deterioration ranging from
40.9 to 90.0%. Thus, if these patients had undergone
surgery under general anesthesia, a shunt would have
been placed unnecessarily in 10.0–59.1% of the patients.
Negative predictive values were found ranging from 94.4
to 99.2%, meaning that in 0.8–5.6% of the patients, EEG
would have failed to detect neurologic deficit and a shunt
would have been wrongly withheld [7, 25–27]. PPVs and
NPVs of TCD as sole modality in detecting cerebral
ischemia range from 19 to 75% and 97 to 99%, respec-
tively, depending on criteria used as indicative for
shunting [28–30]. These varying figures might reflect
differences in subjective interpretations of EEG tracings
and/or TCD recordings. Both techniques therefore require
well-trained personnel, are time-consuming, and thus are
costly.
The mean hospital costs for CEA found in our series are
comparable to those found in other studies. Recently,
Buisman et al. [31] determined hospital resource use and
costs for ischemic stroke and TIA in the Netherlands. Costs
were estimated at € 6836 ± 2862, with surgery and hos-
pitalization (average 4.8 inpatient days) as main determi-
nants, accounting for 51 and 34% of the total costs,
respectively, similar to our series.
It is important to note that a variety of methods other
than those we studied are available to determine the need
for a shunt. Moreover, some surgeons prefer the routine use
of a shunt, and others perform CEA under loco-regional
anesthesia making neuromonitoring unnecessary. In the
Netherlands, a selective shunting strategy is used in the
large majority of CEAs ([90%). EEG is most frequently
used (43%), followed by EEG combined with TCD (40%).
SPM is only used in 1.6% of all CEAs [4]. A recent meta-
analysis could not demonstrate a clinical benefit of one
strategy above the other in terms of 30-day death or stroke
rate [9]. Both routine shunting as well as selective shunt-
ing, whatever modality used, seem to be acceptable.
There are several limitations to our study. First, due to
its retrospective character, this study had to rely on
Fig. 2 Cost-effectiveness of SPM versus EEG/TCD. The effect
(stroke/death) is expressed as risk difference (RD). Estimates are
adjusted for age, risk factors (smoking, coronary artery disease,
peripheral artery disease, diabetes mellitus), index event, and
ipsilateral and contralateral degree of stenosis
Fig. 3 Sensitivity analysis to assess the potential impact of
misclassification on the outcome, specifically to assess the impact
of an event going undetected. Triangles (and dashed confidence
ellipse) represent a scenario in which a random non-event in
hospital A is converted into an event; the crosses (dotted confidence
ellipse) represent a scenario in which a random non-event in
hospital B is converted into an event
World J Surg (2017) 41:2959–2967 2965
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completeness of existing data registries. Several patients
were excluded due to missing data (Fig. 1). Furthermore,
cost analysis is dependent on the accuracy of registration of
resources used during the admission. Under-registration
can lead to erroneous lower costs, but this may have
occurred in both groups. Moreover, since there was a rather
large difference in costs between the two groups, unequal
under-registration is not likely to affect the outcome of the
study. Under-registration or differences in definition of
certain complications might also explain the differences
found in non-fatal strokes, deaths, nerve injuries, and
bleeding. Second, the results may have been confounded
by the fact that the two strategies were performed in dif-
ferent hospitals, although both the participating hospitals
are very comparable midsize teaching hospitals using
similar guidelines and standards. Third, both cohorts con-
sist of relatively small numbers of patients, with even
smaller numbers of adverse events. The sample size is too
small to rule out a type II error for the stroke or death
outcome between the SPM and EEG/TCD cohorts.
Therefore, we can only make cautious statements regarding
the true effect of both strategies in terms of stroke or death
rate. The rates found in our series do, however, correspond
with those found in the literature. Fourth, as discussed
earlier, the cutoff point for shunt insertion in the SPM
cohort was quite high. While excessive shunt use is bene-
ficial for training purposes, it may increase the intraoper-
ative stroke risk. We do not know whether more neurologic
events would have occurred if a lower value had been used,
which, in case, would affect the results of the cost-effec-
tiveness analysis. Finally, this study only addresses SPM
and EEG/TCD as decision-making modality. There are,
however, many more strategies advocated. Inclusion of
other modalities too would be of value when looking for
the most cost-effective strategy.
In conclusion, although this study is limited by its small
sample size and retrospective nature, the primary clinical
outcomes found are comparable to those in the literature.
There is, however, a significant difference in admission
between both strategies. Therefore, SPM might, although
nowadays virtually abandoned for reasons, still be con-
sidered as a modality to indicate the need for shunting from
a cost-effectiveness point of view.
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